| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 114,4 k € | +54.4% | 74,1 k € | -37.7% | 118,8 k € | -12.1% | 135,2 k € | +15.7% | 116,8 k € | +12.1% | 104,2 k € | -37.0% | 165,6 k € | +39.0% | 119,1 k € | -21.5% | 151,7 k € | -12.7% | 173,8 k € | +309.6% | 42,4 k € | -74.0% | 163,5 k € | -5.7% | 173,4 k € | -18.0% | 211,5 k € | -25.2% | 282,8 k € | +41.3% | 200,2 k € | -22.4% | 258,0 k € | +33.8% | 192,8 k € | -0.0% | 192,9 k € | |
| EBITDA | 116,1 k € | +900.0% | 11,6 k € | -85.8% | 82,0 k € | -11.6% | 92,7 k € | +25.3% | 74,0 k € | +12.6% | 65,7 k € | -46.7% | 123,2 k € | +50.0% | 82,1 k € | -29.5% | 116,6 k € | -14.8% | 136,8 k € | +58.3% | 86,4 k € | -32.0% | 127,1 k € | -10.0% | 141,3 k € | -20.1% | 176,7 k € | -3.8% | 183,6 k € | +9.4% | 167,9 k € | -26.1% | 227,0 k € | +39.6% | 162,6 k € | +0.2% | 162,2 k € | |
| Operating profit | 94,0 k € | +1296.1% | -7,9 k € | -112.5% | 62,6 k € | -19.5% | 77,8 k € | +17.2% | 66,4 k € | +26.4% | 52,5 k € | -48.4% | 101,8 k € | +141.6% | 42,1 k € | -40.1% | 70,4 k € | -20.0% | 88,0 k € | +122.5% | 39,5 k € | -48.1% | 76,1 k € | -25.0% | 101,5 k € | -22.6% | 131,0 k € | +24.2% | 105,5 k € | +12.0% | 94,2 k € | -35.4% | 145,8 k € | +21.7% | 119,8 k € | +1.7% | 117,8 k € | |
| Profit/loss | 66,3 k € | +909.3% | -8,2 k € | -118.4% | 44,6 k € | -12.0% | 50,7 k € | +6.8% | 47,4 k € | +25.9% | 37,6 k € | -47.3% | 71,5 k € | +182.0% | 25,3 k € | -42.4% | 44,0 k € | -27.6% | 60,8 k € | +102.3% | 30,1 k € | -41.3% | 51,3 k € | -28.9% | 72,1 k € | -20.1% | 90,3 k € | +50.7% | 59,9 k € | -22.1% | 76,8 k € | -15.4% | 90,8 k € | +7.5% | 84,5 k € | -4.5% | 88,5 k € | |
| Equity | 309,7 k € | +10.0% | 281,5 k € | -22.1% | 361,6 k € | +5.7% | 342,0 k € | +2.0% | 335,4 k € | +10.7% | 303,0 k € | +14.2% | 265,3 k € | -35.3% | 409,9 k € | +6.6% | 384,5 k € | +12.9% | 340,5 k € | +21.8% | 279,6 k € | +12.1% | 249,6 k € | -27.1% | 342,3 k € | +26.7% | 270,1 k € | -13.9% | 313,9 k € | +23.6% | 254,0 k € | +43.4% | 177,2 k € | +19.0% | 148,9 k € | +62.9% | 91,4 k € | |
| Total assets | 439,6 k € | +8.9% | 403,7 k € | -8.3% | 440,2 k € | -4.5% | 461,2 k € | +15.7% | 398,7 k € | +12.4% | 354,8 k € | +8.9% | 326,0 k € | -26.7% | 444,8 k € | +2.0% | 436,3 k € | +10.9% | 393,3 k € | +25.5% | 313,4 k € | -39.6% | 518,8 k € | +13.8% | 455,7 k € | +10.7% | 411,8 k € | -24.7% | 546,7 k € | +18.4% | 461,7 k € | -4.2% | 481,9 k € | +26.6% | 380,8 k € | +26.5% | 301,1 k € | |
| Cash | 385,5 k € | +18.0% | 326,8 k € | -13.8% | 378,9 k € | -3.8% | 394,0 k € | +2.4% | 384,8 k € | +14.7% | 335,3 k € | +21.2% | 276,7 k € | -16.2% | 330,1 k € | +28.4% | 257,0 k € | +46.8% | 175,1 k € | +49.1% | 117,4 k € | -57.3% | 274,8 k € | +18.5% | 231,8 k € | +61.8% | 143,2 k € | -33.7% | 216,1 k € | +30.8% | 165,2 k € | +85.1% | 89,3 k € | -15.2% | 105,3 k € | +67.0% | 63,0 k € | |
| Debts | 129,9 k € | +6.3% | 122,2 k € | +55.4% | 78,6 k € | -34.0% | 119,1 k € | +88.3% | 63,3 k € | +22.6% | 51,6 k € | -14.2% | 60,2 k € | +75.8% | 34,2 k € | -32.7% | 50,8 k € | -1.6% | 51,6 k € | +59.9% | 32,3 k € | -83.1% | 191,0 k € | +435.2% | 35,7 k € | -45.3% | 65,3 k € | -56.6% | 150,6 k € | -27.5% | 207,7 k € | -31.8% | 304,8 k € | +31.4% | 231,9 k € | +10.6% | 209,7 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 0,9 | 0,9 | 1 | 1 | 0,9 | 1 | 1 | 0,9 | 0,9 | 0,9 | |||||||||||||||||||
Private limited company · Seraing · incorporated on 28/12/2001
Private limited company profitable and well capitalised. Cash position rising (+18.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOCTEUR MANS - MALADIES ET CHIRURGIE DES YEUX is a Private limited company incorporated in 2001. Its registered office is in Seraing.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette